leisure time -WSS

leisure time

author：hotspot 2025-09-06 04:30:20 - browse：8921

Two boxes of Humira and a Humira pen on the side — first opinion coverage from STAT — David J. Phillip/AP

It’s been one year since the launch of the first adalimumab biosimilar for Humira in the United States, which was followed by eight additional adalimumab biosimilar launches. These nine FDA-approved products offer lower-cost alternatives to the world’s bestselling drug, Humira, used to treat rheumatoid arthritis, Crohn’s disease, and other autoimmune disorders. This made 2023 a watershed year for millions of U.S. patients paying too much for their necessary medications.

But so far, that vision hasn’t come to fruition, because policymakers haven’t taken the action necessary to be sure these lower-cost products are accessible for patients. If they fail to act, the U.S. health care system could lose up to $133 billion in savings and leave patients without access to the medicines they need.

Biosimilars are safe and effective treatments referencing biologic drugs. They are market disruptors, forcing lower prices for biologic medicines. The cost savings from reference biologic products begins almost immediately when biosimilars enter the market and continues over time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Elevance, private equity launch primary care company

WSS

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Sanofi strikes deal with Novavax, boosting the vaccine maker

At least 12 people were injured in a blast at a port in northwest Turkey

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

hotspot

leisure time

explore

Walensky prepares to leave CDC — and Congress — behind

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

Affirmative action in medical school literally saved lives

Dairy farmers resist CDC push for PPE against bird flu virus

Jerome Adams on the need for new antivirals for Covid

Readout LOUD podcast: What to know about H5N1 bird flu

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

上半场结束，绿军52-50领先雄鹿队。

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

explore

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Why workplace violence is so common in health care

Moderna hits safety problems in bold bid to reinvent medicine

At least 12 people were injured in a blast at a port in northwest Turkey

focus

entertainment

focus

focus